Age at start of vaccine course

Vaccine type

Vaccine brand

Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease)

2–9 years

MenACWY

Preferably Menveo or Nimenrix, otherwise Menactra

1 dose

MenB

Bexsero

2 doses (8 weeks between doses)

≥10 years

MenACWYa

Preferably Menveo or Nimenrix, otherwise Menactra

1 dose

MenB

Bexsero

2 doses (8 weeks between doses)

MenB

Trumenba

2 doses (6 months between doses)

a There is no registered upper age limit for use of Menveo. Although both Menactra and Nimenrix are registered for use up to 55 years of age only, either of these brands can be given to people >55 years of age.

Previous

Table. Recommendations for meningococcal vaccines by age group

Next

Table. Recommendations for pneumococcal vaccination using 23vPPV for Aboriginal and Torres Strait Islander adults who do not have a condition(s) associated with an increased risk of invasive pneumococcal disease

Last updated: 
5 June 2018
Last reviewed: 
5 June 2018